Hi @StevieBuoy
This information straight from the lips of our CEO.
“We’ve got enough cash to get through the approval processes and then we’d have to tap the well again, but you’d be looking at a significantly bigger market cap as we continue to do as we raise capital, the market cap keeps getting much bigger. The next time we hit the well, we should be looking maybe at a 10 per cent raise against a far bigger number to get into commercial. Now, I know the big funds in our top four have supported us to say, “We will go all the way commercially…” and they’ll back us with that, so I’m not worried about scratching around for capital to start to raise the commercial profile of the company. ‘’
No need for others wild speculation of 40% dilution if we agree the next capital raise will come from the NASDAQ IPO duel listing.
With the above statement from our CEO in mind I would suggest US$50m will be the target amount to raise, obviously this would be a function of the share price at the time.
We are talking the same market cap with you suggesting possibly 20% dilution to achieve the US$100m, and he does say maybe a 10% raise.
WP to date has displayed a propensity to raise what is required verses the maximum he can, I don’t believe US$100m at that time will be required to go commercial.
I’m aware of some conjecture about the text verses the verbal interview, where 4th quarter may have been the nasdaq timeframe mentioned, to me that would be a better timeline as by then we will have 25-30 DurAVR implanted. The further we progress the higher the share price should be.
- Forums
- ASX - By Stock
- AVR
- Commentary on AGM questions.
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

Commentary on AGM questions., page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1000 | 6.000 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.270 | 200 | 1 |
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online